Related Articles
Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long‑acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors
Insulin‑like growth factor‑II mRNA‑binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma
Sex comb on midleg like‑2 is a novel specific marker for the diagnosis of gastroenteropancreatic neuroendocrine tumors
Analysis of IMP3 expression in primary tumor and stromal cells in patients with colorectal cancer
Prognostic impact of p16 and p21 on gastroenteropancreatic neuroendocrine tumors